Page last updated: 2024-12-08

1,3-diacetylchloramphenicol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-Diacetylchloramphenicol is a **derivative of the antibiotic chloramphenicol**. It's not a commonly used antibiotic itself, but it holds significance in research for several reasons:

**1. Potential Therapeutic Applications:**

* **Antimicrobial activity:** While not as widely used as chloramphenicol, 1,3-diacetylchloramphenicol retains some antimicrobial activity. Research investigates its potential against specific bacteria and its possible role in combination therapies.
* **Pro-drug potential:** The diacetyl groups might act as pro-drug moieties, meaning they could be inactive when administered but converted into the active chloramphenicol within the body. This could potentially overcome some of the limitations of chloramphenicol, such as its poor oral bioavailability.

**2. Research Tool:**

* **Synthesis and Chemical Modification Studies:** 1,3-diacetylchloramphenicol serves as a model compound for studying chemical modifications of chloramphenicol. Researchers might use it to develop new analogs with improved properties like increased potency, reduced toxicity, or extended half-life.
* **Structure-Activity Relationship Studies:** By comparing the activity of 1,3-diacetylchloramphenicol with other chloramphenicol derivatives, researchers can gain insights into the structural features responsible for its biological activity.

**3. Historical Importance:**

* **Chloramphenicol History:** The discovery and study of 1,3-diacetylchloramphenicol have been important in understanding the metabolism and pharmacokinetics of chloramphenicol itself. It was a significant step in the development of chloramphenicol as an antibiotic.

**Important Note:** 1,3-Diacetylchloramphenicol, like chloramphenicol, is a potent drug with potential side effects. Its use in clinical settings is very limited. Research focuses on understanding its potential benefits and risks, with the ultimate goal of developing safer and more effective therapeutic agents.

1,3-diacetylchloramphenicol: RN given refers to (R-(R*,R*))-isomer; RN for cpd without isomeric designation not avail 10/92; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID160933
CHEMBL ID4168656
MeSH IDM0206066

Synonyms (9)

Synonym
acetamide,n-[(1r,2r)-2-(acetyloxy)-1-[(acetyloxy)methyl]-2-(4-nitrophenyl)ethyl]-2,2-dichloro-
1,3-diacetylchloramphenicol
10318-17-9
[(2r,3r)-3-acetyloxy-2-[(2,2-dichloroacetyl)amino]-3-(4-nitrophenyl)propyl] acetate
acetamide, n-(2-(acetyloxy)-1-((acetyloxy)methyl)-2-(4-nitrophenyl)ethyl)-2,2-dichloro-, (r-(r*,r*))-
1,3-dacp
DTXSID80145685
(1r,2r)-3-acetoxy-2-[(dichloroacetyl)amino]-1-(4-nitrophenyl)propyl acetate
CHEMBL4168656
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1355415Antimycobacterial activity against Mycobacterium intracellulare ATCC 23068 after 70 to 74 hrs by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355413Antimicrobial activity against Pseudomonas aeruginosa ATCC 2108 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355416Antimycobacterial activity against Mycobacterium tuberculosis ATCC 25177 after 5 days by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355411Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 1708 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355412Antimicrobial activity against Escherichia coli ATCC 2452 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]